Mitchell Rozman
Harrison Township, MINPI 1316564958
Payments from drug & device makers
Across 80 payments — averaging $49.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kestra Medical Technology Services, Inc.$638
- Inari Medical, Inc.$541
- Boston Scientific$426
- Shockwave Medical, Inc$272
- Philips North America LLC$252
- E.r. Squibb & Sons, L.L.C.$218
- plus $2K from 20 others
What the payments were for
- Food & beverage$3,77796%
- Education$1444%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 13 | $638 |
| Inari Medical, Inc. | 6 | $541 |
| Boston Scientific | 5 | $426 |
| Shockwave Medical, Inc | 3 | $272 |
| Philips North America LLC | 2 | $252 |
| E.r. Squibb & Sons, L.L.C. | 6 | $218 |
| Edwards Lifesciences | 3 | $209 |
| Penumbra, Inc. | 1 | $155 |
| Abbott | 1 | $144 |
| AstraZeneca(2 entities) | 3 | $129 |
| Novo Nordisk | 5 | $121 |
| Cardiva Medical, Inc. | 1 | $118 |
| AbbVie | 4 | $97 |
| Cvrx, Inc. | 1 | $92 |
| Amgen | 4 | $86 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $76 |
| Abiomed | 2 | $58 |
| Boehringer Ingelheim | 3 | $56 |
| Medtronic | 2 | $50 |
| Bayer | 3 | $46 |
| Stryker | 2 | $34 |
| La Jolla Pharmaceutical Company | 2 | $29 |
| Lantheus Medical Imaging, Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Merck | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$485
- CT THROMBECTOMY SYSTEM KIT$485
- Assure WCD$231
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$161
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$155
- Indigo System$155
- WATCHMAN Access System$144
- ENSITE$144
- Azurion 7 M20$127
- ELIQUIS$126
- ENCORE$125
- WATCHMAN FLX$120
- Cardiva VASCADE 6/7F VCS$118
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 19 | $13,745 |
| Atorvastatin Calcium | 48 | $941 |
| Metoprolol Succinate | 29 | $729 |
| ClopidogrelClopidogrel Bisulfate | 33 | $677 |
| Losartan Potassium | 39 | $428 |
| Rosuvastatin Calcium | 20 | $327 |
| Furosemide | 14 | $170 |
| Metoprolol Tartrate | 12 | $112 |
| Lisinopril | 16 | $41 |
| Amlodipine Besylate | 16 | $23 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $129 | $13,74519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few providers in Michiganon file to place this against a meaningful peer group, so we don't.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.